Pediatric Anthrax Clinical Management

Bradley, John S.; Peacock, Georgina; Krug, Steven E.; Bower, William A.; Cohn, Amanda C.; Meaney-Delman, Dana; Pavia, Andrew T.

Back to Previous Page

- Add this to...
- Twitter
- Facebook
- Google Bookmarks
- LinkedIn

Pediatric Anthrax Clinical Management

Published Date:

May 2014

Source:

Pediatrics. 2014; 133(5):e1411-e1436

Language:

English

[PDF-585.17 KB]

Details:

Alternative Title:

Pediatrics

Personal Author:

Bradley, John S. ; Peacock, Georgina ; Krug, Steven E. ; Bower, William A. ; Cohn, Amanda C. ; ... More ▼

Corporate Authors:

AAP COMMITTEE ON INFECTIOUS DISEASES and DISASTER PREPAREDNESS ADVISORY COUNCIL

Description:

Anthrax is a zoonotic disease caused by Bacillus anthracis, which has multiple routes of infection in humans, manifesting in different initial presentations of disease. Because B anthracis has the potential to be used as a biological weapon and can rapidly progress to systemic anthrax with high mortality in those who are exposed and untreated, clinical guidance that can be quickly implemented must be in place before any intentional release of the agent. This document provides clinical guidance for the prophylaxis and treatment of neonates, infants, children, adolescents, and young adults up to the age of 21 (referred to as "children") in the event of a deliberate B anthracis release and offers guidance in areas where the unique characteristics of children dictate a different clinical recommendation from adults.

Subject:

[+]

Pubmed ID:

24777226

Pubmed Central ID:

PMC4479255

Document Type:

Journal Article

Funding:

CC999999/Intramural CDC HHS/United States

Place as Subject:

United States

Collection(s):

CDC Public Access

Main Document Checksum:

[+]

Supporting Files:

nihms699373.nxml

text/xml

No Related Documents.

You May Also Like:

Conference report on public health and clinical guidelines for anthrax

Personal Author:

Stern, Eric Jacob; Uhde, Kristin Broome; Shadomy, Sean Vincent; Messonnier, Nancy E.;

Corporate Authors:

Centers for Disease Control and Prevention (U.S.)

Published Date:

April 2008

Source:

Emerging infectious diseases. 2008; 14(4).

Description:

Suggested citation for this article: Stern EJ, Uhde KB, Shadomy SV, Messonnier N. Conference report on public health and clinical guidelines for anthrax [conference summary]. Emerg Infect Dis [serial on the Internet]. 2008 Apr [date cited]. Available...

Status:

current

File Type:

[PDF - 120.26 KB]
Identifying Meningitis During an Anthrax Mass Casualty Incident: Systematic Review of Systemic Anthrax Since 1880

Personal Author:

Katharios-Lanwermeyer, Stefan; Holty, Jon-Erik; Person, Marissa; Sejvar, James; Haberling, Dana; Tubbs, Heather; Meaney-Delman, Dana; Pillai, Satish K.; Hupert, Nathaniel; Bower, William A.; Hendricks, Katherine;

Published Date:

Mar 29 2016

Source:

Clin Infect Dis. 62(12):1537-1545.

Description:

BACKGROUNDBacillus anthracis, the causative agent of anthrax, is a potential bioterrorism agent. Anthrax meningitis may be a manifestation of B. anthracis infection, has high mortality, and requires more aggressive treatment than anthrax without meni...

File Type:

[PDF - 529.38 KB]
Clinical framework and medical countermeasure use during an anthrax mass-casualty incident

Personal Author:

Bower, William A.; Hendricks, Katherine A.; Pillai, Satish K.; Guarnizo, Julie T.; Meaney-Delman, Dana;

Corporate Authors:

High-Consequence Pathogens and Pathology.. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Division of Preparedness and Emerging Infections.. National Center for Emerging and Zoonotic Infectious Diseases (U.S.). Office of the Director..

Published Date:

December 4, 2015

Series:

MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports ; v. 64, no. RR-4

Description:

In 2014, CDC published updated guidelines for the prevention and treatment of anthrax (Hendricks KA, Wright ME, Shadomy SV, et al. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. Emer...

File Type:

[PDF - 1.24 MB]
An Ounce of Prevention is a Ton of Work: Mass Antibiotic Prophylaxis for Anthrax, New York City, 2001

Personal Author:

Blank, Susan; Moskin, Linda C.; Zucker, Jane R.;

Published Date:

Jun 2003

Source:

Emerg Infect Dis. 9(6):615-622.

Description:

Protocols for mass antibiotic prophylaxis against anthrax were under development in New York City beginning in early 1999. This groundwork allowed the city's Department of Health to rapidly respond in 2001 to six situations in which cases were identi...

File Type:

[PDF - 198.58 KB]
Anthrax as a biological weapon, 2002 : updated recommendations for management

Personal Author:

Inglesby, Thomas V.; O’Toole, Tara; Henderson, Donald A.; Bartlett, John G.; Ascher, Michael S.; Eitzen, Edward; Friedlander, Arthur M.; Gerberding, Julie L.; Hauer, Jerome; Hughes, James M.; McDade, Joseph E.; Osterholm, Michael T.; Parker, Gerald; Perl, Trish M.; Russell, Philip K.; Tonat, Kevin;

Corporate Authors:

Working Group on Civilian Biodefense.. Johns Hopkins Center for Civilian Biodefense Strategies.. U.S. Army Medical Research Institute of Infectious Diseases‏.. Centers for Disease Control and Prevention (U.S.). University of Minnesota School of Public Health. Center for Infectious Disease Research and Policy..

Published Date:

May 1, 2002

Source:

JAMA : the journal of the American Medical Association. 2002; 287(17):2236-52.

Description:

OBJECTIVE: To review and update consensus-based recommendations for medical and public health professionals following a Bacillus anthracis attack against a civilian population.PARTICIPANTS: The working group included 23 experts from academic medical ...

Status:

current

File Type:

[PDF - 369.19 KB]